These latter proteins may therefore be of highest interest for functional studies on the GluA2/3 receptor subtype, and GluA3-dependent disease mechanisms, like the induction of Amyloid-β pathology in Alzheimer’s disease models [15]. This evidence concerns the gene GRIA3 and early-onset autosomal dominant Alzheimer disease.